JP6333287B2 - 時間に対する統計的分析に基づく画像診断応用におけるセグメンテーション - Google Patents
時間に対する統計的分析に基づく画像診断応用におけるセグメンテーション Download PDFInfo
- Publication number
- JP6333287B2 JP6333287B2 JP2015548492A JP2015548492A JP6333287B2 JP 6333287 B2 JP6333287 B2 JP 6333287B2 JP 2015548492 A JP2015548492 A JP 2015548492A JP 2015548492 A JP2015548492 A JP 2015548492A JP 6333287 B2 JP6333287 B2 JP 6333287B2
- Authority
- JP
- Japan
- Prior art keywords
- value
- statistical
- segmentation
- statistical parameter
- calculating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000011218 segmentation Effects 0.000 title claims description 160
- 238000002059 diagnostic imaging Methods 0.000 title claims description 11
- 238000007619 statistical method Methods 0.000 title description 3
- 238000004458 analytical method Methods 0.000 claims description 57
- 239000002872 contrast media Substances 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 52
- 230000004044 response Effects 0.000 claims description 26
- 230000003902 lesion Effects 0.000 claims description 19
- 230000009466 transformation Effects 0.000 claims description 11
- 238000004590 computer program Methods 0.000 claims description 9
- 206010058558 Hypoperfusion Diseases 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 230000000875 corresponding effect Effects 0.000 description 65
- 239000000243 solution Substances 0.000 description 38
- 210000001519 tissue Anatomy 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 25
- 230000006870 function Effects 0.000 description 25
- 238000002604 ultrasonography Methods 0.000 description 23
- 239000002245 particle Substances 0.000 description 18
- 230000010412 perfusion Effects 0.000 description 14
- 238000003384 imaging method Methods 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 7
- 239000013598 vector Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000008081 blood perfusion Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000037516 chromosome inversion disease Diseases 0.000 description 3
- 239000002961 echo contrast media Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 206010019695 Hepatic neoplasm Diseases 0.000 description 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 238000005315 distribution function Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 241001116459 Sequoia Species 0.000 description 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 208000023958 prostate neoplasm Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005295 random walk Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/10—Segmentation; Edge detection
- G06T7/174—Segmentation; Edge detection involving the use of two or more images
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
- G06T7/0014—Biomedical image inspection using an image reference approach
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10132—Ultrasound image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/20—Special algorithmic details
- G06T2207/20112—Image segmentation details
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Computer Vision & Pattern Recognition (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Quality & Reliability (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Image Processing (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12199175 | 2012-12-21 | ||
| EP12199175.6 | 2012-12-21 | ||
| PCT/EP2013/077152 WO2014096041A1 (en) | 2012-12-21 | 2013-12-18 | Segmentation in diagnostic imaging applications based on statistical analysis over time |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016501599A JP2016501599A (ja) | 2016-01-21 |
| JP2016501599A5 JP2016501599A5 (ko) | 2017-02-02 |
| JP6333287B2 true JP6333287B2 (ja) | 2018-05-30 |
Family
ID=47721895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548492A Active JP6333287B2 (ja) | 2012-12-21 | 2013-12-18 | 時間に対する統計的分析に基づく画像診断応用におけるセグメンテーション |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9734584B2 (ko) |
| EP (1) | EP2936433B1 (ko) |
| JP (1) | JP6333287B2 (ko) |
| KR (1) | KR102166648B1 (ko) |
| CN (1) | CN104885121B (ko) |
| BR (1) | BR112015014164B1 (ko) |
| WO (1) | WO2014096041A1 (ko) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10130342B2 (en) | 2007-12-28 | 2018-11-20 | Bracco Suisse Sa | Initialization of fitting parameters for perfusion assessment based on bolus administration |
| WO2015155380A1 (en) | 2014-04-07 | 2015-10-15 | Bracco Suisse Sa | Estimation of acoustic level in-situ with non-fundamental analysis |
| CN105357575A (zh) * | 2014-08-20 | 2016-02-24 | 中兴通讯股份有限公司 | 一种视频图像处理装置和方法 |
| JP6759550B2 (ja) * | 2015-03-04 | 2020-09-23 | ソニー株式会社 | 情報処理装置、プログラム、情報処理方法及び観察システム |
| US11166700B2 (en) | 2015-03-25 | 2021-11-09 | Koninklijke Philips N.V. | Optimal ultrasound-based organ segmentation |
| RU2702090C2 (ru) | 2015-03-31 | 2019-10-04 | Конинклейке Филипс Н.В. | Калибровка ультразвукового, основанного на эластичности, отображения границы очага поражения |
| US10433817B2 (en) | 2015-12-10 | 2019-10-08 | Bracco Suisse S.A. | Detection of immobilized contrast agent with dynamic thresholding |
| KR101956308B1 (ko) * | 2016-11-04 | 2019-03-08 | 서강대학교산학협력단 | 광음향 영상의 배경 노이즈를 제거하는 시스템 및 그 방법 |
| WO2019104230A1 (en) * | 2017-11-21 | 2019-05-31 | The Charles Stark Draper Laboratory, Inc. | System and method for imaging and localization of contrast-enhanced features in the presence of accumulating contrast agent in a body and amplification of features in ultrasound-generated images |
| CN108542422A (zh) * | 2018-03-06 | 2018-09-18 | 武汉轻工大学 | B超图像优化方法、装置及计算机可读存储介质 |
| WO2019175664A1 (en) * | 2018-03-13 | 2019-09-19 | Trust Bio-Sonics, Inc. | Composition and methods for sensitive molecular analysis |
| US10950016B2 (en) | 2018-06-11 | 2021-03-16 | Shanghai United Imaging Healthcare Co., Ltd. | Systems and methods for reconstructing cardiac images |
| WO2020097298A1 (en) * | 2018-11-09 | 2020-05-14 | Georgia Tech Research Corporation | Systems and methods for ultrasound imaging and focusing |
| CN113108916B (zh) * | 2021-03-17 | 2022-04-12 | 国网江西省电力有限公司电力科学研究院 | 基于复杂网络与Page Rank随机游走的多点温度融合监测方法 |
| CN113393425B (zh) * | 2021-05-19 | 2022-04-26 | 武汉大学 | 胃黏膜染色放大成像的微血管分布对称性量化方法 |
| WO2023039591A1 (en) * | 2021-09-13 | 2023-03-16 | Board Of Regents, The University Of Texas System | Identifying objects in magnetic resonance images |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN172208B (ko) | 1990-04-02 | 1993-05-01 | Sint Sa | |
| US5445813A (en) | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
| AU636481B2 (en) | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| IL104084A (en) | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them |
| PL182223B1 (pl) | 1993-12-15 | 2001-11-30 | Bracco Research Sa | Biokompatybilna faza rozproszona do otrzymywania srodka kontrastowego do badan ultradzwiekowych, srodek kontrastowy do badan ultradzwiekowych, suchy preparat srodka kontrastowego oraz dwuskladnikowy zestaw do otrzymywania srodka kontrastowego do badan ultradzwiekowych PL PL PL |
| JP3946815B2 (ja) * | 1997-06-11 | 2007-07-18 | 東芝医用システムエンジニアリング株式会社 | 超音波診断装置 |
| JP4467673B2 (ja) * | 1999-08-19 | 2010-05-26 | 株式会社東芝 | 超音波診断装置 |
| KR101025490B1 (ko) | 2003-06-12 | 2011-04-04 | 브라코 인터내셔날 비.브이. | 초음파 콘트라스트 조영에서 보충 커브 피팅을 통한 혈류 개산 |
| WO2006018433A1 (en) | 2004-08-18 | 2006-02-23 | Bracco Research Sa | Gas-filled microvesicles composition for contrast imaging |
| JP4651375B2 (ja) * | 2004-12-16 | 2011-03-16 | 株式会社日立メディコ | 医用画像表示装置及びその方法 |
| US8036437B2 (en) * | 2005-04-14 | 2011-10-11 | Bracco Research Sa | Perfusion assessment method and system based on animated perfusion imaging |
| US9072492B2 (en) * | 2007-12-28 | 2015-07-07 | Bracco Suisse Sa | Quantification analysis of immobilized contrast agent in medical imaging applications |
| CA2761596C (en) | 2009-06-08 | 2017-11-07 | Bracco Suisse S.A. | Auto-scaling of parametric images |
| RU2541175C2 (ru) * | 2009-06-30 | 2015-02-10 | Конинклейке Филипс Электроникс Н.В. | Количественный анализ перфузии |
| EP2473972B1 (en) | 2009-09-01 | 2019-11-06 | Bracco Suisse SA | Method for producing medical parametric images |
-
2013
- 2013-12-18 JP JP2015548492A patent/JP6333287B2/ja active Active
- 2013-12-18 BR BR112015014164-1A patent/BR112015014164B1/pt active IP Right Grant
- 2013-12-18 WO PCT/EP2013/077152 patent/WO2014096041A1/en active Application Filing
- 2013-12-18 EP EP13814107.2A patent/EP2936433B1/en active Active
- 2013-12-18 US US14/654,449 patent/US9734584B2/en active Active
- 2013-12-18 KR KR1020157019736A patent/KR102166648B1/ko active IP Right Grant
- 2013-12-18 CN CN201380066958.4A patent/CN104885121B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2936433B1 (en) | 2018-09-19 |
| CN104885121B (zh) | 2018-08-31 |
| US9734584B2 (en) | 2017-08-15 |
| KR20150099823A (ko) | 2015-09-01 |
| EP2936433A1 (en) | 2015-10-28 |
| JP2016501599A (ja) | 2016-01-21 |
| KR102166648B1 (ko) | 2020-10-19 |
| BR112015014164A2 (pt) | 2017-07-11 |
| BR112015014164A8 (pt) | 2019-10-22 |
| CN104885121A (zh) | 2015-09-02 |
| BR112015014164B1 (pt) | 2021-12-07 |
| US20150348277A1 (en) | 2015-12-03 |
| WO2014096041A1 (en) | 2014-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6333287B2 (ja) | 時間に対する統計的分析に基づく画像診断応用におけるセグメンテーション | |
| EP2234543B1 (en) | Quantification analisys of immobilized contrast agent in medical imaging applications | |
| JP5719892B2 (ja) | 動的灌流画像法に基づく灌流診断法およびそのシステム | |
| JP4706003B2 (ja) | 超音波造影画像において補充曲線フィッティングを用いる血流評価法 | |
| JP5593382B2 (ja) | パラメトリック画像の自動スケーリング | |
| JP5628314B2 (ja) | 経時的な動的挙動に基づくパラメトリック画像 | |
| JP6803909B2 (ja) | ダイナミック閾値を有する固定化造影剤の検出 | |
| CN102573647A (zh) | 用于监测肝脏治疗的肝脏血流的对比增强超声评估 | |
| CA2624636C (en) | Instantaneous visualization of contrast agent concentration in imaging applications | |
| US11607196B2 (en) | Initialization of fitting parameters for perfusion assessment based on bolus administration | |
| Schlosser et al. | Echoscintigraphy: a new imaging modality for the reduction of color blooming and acoustic shadowing in contrast sonography | |
| Czernuszewicz et al. | A new preclinical ultrasound platform for widefield 3D imaging of rodents | |
| KR102720431B1 (ko) | 동적 역치화에 의한 고정된 조영제의 검출 | |
| US20240366183A1 (en) | Real-time super-resolution ultrasound microvessel imaging and velocimetry | |
| Barrois | Development of quantitative methods for the following of tumoral angiogenesis with dynamic contrast-enhanced ultrasound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161213 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161213 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170808 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170809 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171108 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171212 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180307 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180327 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180424 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6333287 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |